Sort
48,018 grants matching “immunotherapy”
Circulating DNA as a Marker of Treatment Efficacy and Failure in Lung Cancer
$383,156Abhijit Patel · Yale University · R01 · FY2018 · CA
Targeting metabolic stress to induce pancreatic tumor cell death
$383,140Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
CD8 T Cell Replicative Senescence &HIV Disease
$383,126University Of California Los Angeles · R01 · FY2004 · AI
T cell plasticity, fusion proteins and CAR T cell-based immunotherapy of head and neck cancer
$383,100Xinhui Wang · Massachusetts General Hospital · R01 · FY2022 · DE
Addressing cancer disparities in Nigeria through Immuno-oncology Research â The NOLA Program
$383,091T Peter Kingham · Sloan-Kettering Inst Can Research · P20 · FY2024 · CA
Microglia Mediated Inflammation in the Diabetic Retina
$383,054Astrid E Cardona · University Of Texas San Antonio · R01 · FY2019 · EY
Tumor Immunology Institutional Training Grant
$383,014Steven M. Dubinett · University Of California Los Angeles · T32 · FY2009 · CA
Quantitative and Spatially-Resolved Analysis of the Tumor Immune Contexture for Optimal Diagnosis and Treatment of Lung Cancer
$382,983Kurt A Schalper · Yale University · R37 · FY2020 · CA
Quantitative and Spatially-Resolved Analysis of the Tumor Immune Contexture for Optimal Diagnosis and Treatment of Lung Cancer
$382,978Kurt A Schalper · Yale University · R37 · FY2021 · CA
Quantitative and Spatially-Resolved Analysis of the Tumor Immune Contexture for Optimal Diagnosis and Treatment of Lung Cancer
$382,973Kurt A Schalper · Yale University · R37 · FY2022 · CA
Targeting antigen presentation to enhance GVL responses after Bone Marrow Transpl
$382,918Pavan Reddy · University Of Michigan At Ann Arbor · R01 · FY2015 · HL
Augmentation of Immune Response to Head & Neck Squamous Cell Carcinoma via Phosp
$382,892Ivan M Borrello · Johns Hopkins University · P50 · FY2016 · DE
Angiopoietin-2/Tie2 signaling regulation of liver metastasis in pancreatic neuroendocrine tumors
$382,867Minah Kim · Columbia University Health Sciences · R37 · FY2023 · CA
Cytotoxic lymphocyte function PET imaging to predict cancer immunotherapy response
$382,836Umar Mahmood · Massachusetts General Hospital · R01 · FY2021 · CA
Cytotoxic lymphocyte function PET imaging to predict cancer immunotherapy response
$382,836Umar Mahmood · Massachusetts General Hospital · R01 · FY2018 · CA
Cytotoxic lymphocyte function PET imaging to predict cancer immunotherapy response
$382,836Umar Mahmood · Massachusetts General Hospital · R01 · FY2020 · CA
Cytotoxic lymphocyte function PET imaging to predict cancer immunotherapy response
$382,836Umar Mahmood · Massachusetts General Hospital · R01 · FY2017 · CA
Regulation of repetitive elements in cancer by P53 and epigenetic mechanisms
$382,820Katherine B Chiappinelli · George Washington University · R37 · FY2021 · CA
Advancing Cancer Therapy through Groundbreaking Research in Radiation Biology
$382,796David G Kirsch · Roswell Park Cancer Institute Corp · R35 · FY2024 · CA
Enhancing TIL populations and immunotherapy efficacy in melanoma by modulating fucosylation
$382,794Eric Kirk Lau · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2019 · CA
Inducible Regulatory B cells IBREG
$382,792Hans-Christian Reinecker · Massachusetts General Hospital · R01 · FY2015 · AI
Inducible Regulatory B cells IBREG
$382,792Emiko Mizoguchi · Massachusetts General Hospital · R01 · FY2014 · AI
Inducible Regulatory B cells IBREG
$382,792Atsushi Mizoguchi · Massachusetts General Hospital · R01 · FY2012 · AI
Inducible Regulatory B cells IBREG
$382,792Atsushi Mizoguchi · Massachusetts General Hospital · R01 · FY2011 · AI
Microscale Multiplexed Antibody Fc Profiling and Nanoscale Electronic Detection for Rapid and Scalable Point-of-Care Diagnosis of Tuberculosis
$382,775Aniruddh Sarkar · Georgia Institute Of Technology · R01 · FY2025 · AI